Shanghai Bio-heart Biological Technology Co., Ltd. (02185)
Shanghai Bio-heart Biological Technology Co., Ltd., together with its subsidiaries, engages in the research, development, and commercialization of invasive treatment products in China. The company develops Bioheart, a bioresorbable scaffolds system, which is in registration stage for percutaneous coronary intervention procedures for the treatment of coronary artery disease; Iberis, a renal denervation system, which is in cl
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
